110 results
8-K
EX-99.1
5k5l7qsu ymju
14 Dec 23
Bicycle Therapeutics Provides Data Updates for Three Clinical Programs and Strategy Overview at First R&D Day
7:05am
8-K
EX-99.1
scp2rqe4ixlod
2 Nov 23
Bicycle Therapeutics Reports Recent Business Progress and Third Quarter 2023 Financial Results and Announces Upcoming R&D Day
7:05am
8-K
EX-99.1
upebtkpuyg
11 Sep 23
Bicycle Therapeutics Announces Expedited Development Plan for BT8009 in Metastatic Bladder Cancer
7:05am
8-K
EX-99.1
gy4vqho
3 Aug 23
Bicycle Therapeutics Reports Second Quarter 2023 Financial Results and Provides Corporate Update
6:59am
424B5
vif 1gfq2gun
13 Jul 23
Prospectus supplement for primary offering
4:17pm
424B5
ewlogy5oa
12 Jul 23
Prospectus supplement for primary offering
12:00am
424B5
ed6mj6cubgznjij5vs
26 May 23
Prospectus supplement for primary offering
5:25pm
S-3ASR
kjl12j6 2wngc1vki5ql
26 May 23
Automatic shelf registration
4:53pm
8-K
gn8upcq2gy
10 May 23
Bayer and Bicycle Therapeutics Enter Strategic Collaboration for Development of Novel Targeted Radionuclide Therapies in Oncology
7:06am
8-K
EX-99.1
a9wji o2g
10 May 23
Bayer and Bicycle Therapeutics Enter Strategic Collaboration for Development of Novel Targeted Radionuclide Therapies in Oncology
7:06am